Communicable disease control

[키워드] 2019-nCoV assay acute respiratory syndrome acute respiratory syndrome coronavirus age approach arthralgia Asymptomatic asymptomatic individual asymptomatic infections asymptomatic patient asymptomatic patients average average age caused Chain Reaction clinical sample co-morbidities Cohort Communicable disease control Contact Córdoba coronavirus coronavirus 2 Coronavirus infections cough country COVID-19 Critical deaths Department detect develop Dilution Environment and public health feature Fever group Health hospital implication individual individuals Infection Laboratory lack lysis buffer molecular morbidities MOST multiplex nasopharyngeal sample Nasopharyngeal samples objective Occurrence odynophagia pandemic pandemic disease patients required hospitalization PCR assay polymerase chain polymerase chain reaction positive positive control Pre symptomatic disease presymptomatic proportion Public Public health intervention Public health interventions quantification real-time PCR assay reduced regions reported respiratory Result reverse transcription reverse transcription real-time polymerase chain reaction RNA RNA copies RNA copy RT-qPCR SARS-CoV-2 SARS-CoV-2 infected individual SARS-CoV-2 infected individuals SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly higher socio-demographic South America standard curve symptomatic symptomatic and asymptomatic symptomatic patient Symptomatic patients Symptoms target gene Target genes tested the patient Transmission Viral viral load quantification was done were used
[DOI] 10.1186/s12941-020-00397-5 PMC 바로가기 [Article Type] Short Report